Evan Scott Glazer MD, PhD, FACS

Evan S. Glazer, MD, Ph.D., FACS is an Assistant Professor in the Division of Surgical Oncology, Department of Surgery, at The University of Tennessee Health Science Center. He is a researcher and principal investigator in the Center for Cancer Research as well. Dr. Glazer's clinical and research focus is on pancreatic, liver, and biliary tract malignancies including multi-disciplinary care, clinical trials, and basic science research. He manages advanced, multi-disciplinary algorithms to maximize, optimize, and personalize therapies for each patient including surgery, radiation, and chemotherapy. He is double board-certified in complex surgical oncology and general surgery.

Dr. Glazer is a surgeon-scientist who works with experts in surgical oncology, medical oncology, and radiation oncology in both the clinic and the laboratory. He is well-published and has received numerous grants for ongoing research projects including a Career Development Award. His primary research investigates the pancreatic cancer immune tumor microenvironment and the role of TGF-b in pancreatic cancer progression. He is the site principal investigator for 2 clinical trials and treated the first patient on the ALIGN trial for intrahepatic cholangiocarcinoma (bile duct cancer in the liver).

Dr. Glazer is a member of the American College of Surgeons, Society of Surgical Oncology, Association for Academic Surgery, and the American Society of Clinical Oncology. He is a content expert and serves on national committees for the Society for Surgery of the Alimentary Tract, Society of Surgical Oncology, and the Association for Academic Surgery.